SE461223C - mRNA och cDNA för humant fibroblastinterferon, förfarande för deras framställning samt användning därav - Google Patents

mRNA och cDNA för humant fibroblastinterferon, förfarande för deras framställning samt användning därav

Info

Publication number
SE461223C
SE461223C SE8007998A SE8007998A SE461223C SE 461223 C SE461223 C SE 461223C SE 8007998 A SE8007998 A SE 8007998A SE 8007998 A SE8007998 A SE 8007998A SE 461223 C SE461223 C SE 461223C
Authority
SE
Sweden
Prior art keywords
mrna
induced
cdna
dna
interferon
Prior art date
Application number
SE8007998A
Other languages
English (en)
Swedish (sv)
Other versions
SE8007998L (sv
SE461223B (sv
Inventor
Michel Revel
Pierre Tiollais
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11051449&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE461223(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Publication of SE8007998L publication Critical patent/SE8007998L/
Publication of SE461223B publication Critical patent/SE461223B/sv
Publication of SE461223C publication Critical patent/SE461223C/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5412—IL-6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/565—IFN-beta

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
SE8007998A 1979-11-21 1980-11-14 mRNA och cDNA för humant fibroblastinterferon, förfarande för deras framställning samt användning därav SE461223C (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL58765A IL58765A (en) 1979-11-21 1979-11-21 Process for the production of essentially pure messenger rna of human fibroblast interferon and process for the production of interferon beta

Publications (3)

Publication Number Publication Date
SE8007998L SE8007998L (sv) 1981-05-22
SE461223B SE461223B (sv) 1990-01-22
SE461223C true SE461223C (sv) 1997-02-02

Family

ID=11051449

Family Applications (2)

Application Number Title Priority Date Filing Date
SE8007998A SE461223C (sv) 1979-11-21 1980-11-14 mRNA och cDNA för humant fibroblastinterferon, förfarande för deras framställning samt användning därav
SE8603145A SE469660B (sv) 1979-11-21 1986-07-17 Humant fibroblastinterferon-beta, framstaellning och anvaendning daerav

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE8603145A SE469660B (sv) 1979-11-21 1986-07-17 Humant fibroblastinterferon-beta, framstaellning och anvaendning daerav

Country Status (9)

Country Link
US (4) US5468607A (cg-RX-API-DMAC7.html)
JP (3) JP2555279B2 (cg-RX-API-DMAC7.html)
CH (2) CH664967A5 (cg-RX-API-DMAC7.html)
DE (2) DE3043981A1 (cg-RX-API-DMAC7.html)
FR (1) FR2475901A1 (cg-RX-API-DMAC7.html)
GB (1) GB2063882B (cg-RX-API-DMAC7.html)
IL (1) IL58765A (cg-RX-API-DMAC7.html)
IT (1) IT1194820B (cg-RX-API-DMAC7.html)
SE (2) SE461223C (cg-RX-API-DMAC7.html)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56131598A (en) * 1980-03-19 1981-10-15 Japan Found Cancer Novel recombinant plasmid having gene of human fibroblastic interferon messenger rna
US5554513A (en) * 1979-11-21 1996-09-10 Yeda Research & Development Co. Ltd. Production of recombinant human interferon-beta2
US5510472A (en) * 1979-11-21 1996-04-23 Yeda Research And Development Co. Ltd. Production of recombinant human interferon-beta2
DK33181A (da) * 1980-02-06 1981-08-07 Searle & Co Fremgangsmaade til fremstilling af et interferonlignende protein
DE3005897A1 (de) * 1980-02-16 1981-09-03 Hoechst Ag, 6000 Frankfurt Genprodukt eines hoeheren organismus aus einem dieses gen enhtaltenden mikroorganismus
DE3005843A1 (de) * 1980-02-16 1981-09-10 Hoechst Ag, 6000 Frankfurt Genprodukt eines hoeheren organismus aus einem dieses gen enthaltenden mikroorganismus
HU193507B (en) * 1980-04-03 1987-10-28 Biogen Nv Process for producing interferen-like pelypeptides
DE3176011D1 (en) * 1980-06-12 1987-04-23 Japan Found Cancer Plasmid
IL63916A0 (en) * 1980-09-25 1981-12-31 Genentech Inc Microbial production of human fibroblast interferon
US5582824A (en) * 1981-10-19 1996-12-10 Genentech, Inc. Recombinant DES-CYS-TYR-CYS human immune interferon
AU561343B2 (en) * 1981-10-19 1987-05-07 Genentech Inc. Human immune interferon by recombinant dna
JPS58110548A (ja) * 1981-12-24 1983-07-01 Asahi Chem Ind Co Ltd 新規な生理活性ペプチド
US5827694A (en) * 1982-03-08 1998-10-27 Genentech, Inc. DNA encoding non-human animal interferons, vectors and hosts therefor, and recombinant production of IFN polypeptides
US6432677B1 (en) 1982-03-08 2002-08-13 Genentech, Inc. Non-human animal interferons
IE54592B1 (en) * 1982-03-08 1989-12-06 Genentech Inc Anumal interferons, processes involved in their production, compositions containing them, dna sequences coding therefor and espression vehicles containing such sequences and cells transformed thereby
US6936694B1 (en) 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes
DE3220116A1 (de) * 1982-05-28 1983-12-01 Dr. Karl Thomae Gmbh, 7950 Biberach Mikrobiologisch hergestellte (alpha)- und ss-interferone, dna-sequenzen, die fuer diese interferone codieren, mikroorganismen, die diese genetische information enthalten, und verfahren zu ihrer herstellung
US4737462A (en) * 1982-10-19 1988-04-12 Cetus Corporation Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of interferon-β
US5831023A (en) * 1982-11-01 1998-11-03 Genentech, Inc. Recombinant animal interferon polypeptides
US4966843A (en) * 1982-11-01 1990-10-30 Cetus Corporation Expression of interferon genes in Chinese hamster ovary cells
US4855238A (en) * 1983-12-16 1989-08-08 Genentech, Inc. Recombinant gamma interferons having enhanced stability and methods therefor
EP0569687B1 (en) * 1984-05-18 2002-08-21 New England Medical Center Hospitals, Inc. Human IL-1 cDNA sequences encoding biologically-active human IL-1 proteins
US5998578A (en) * 1984-05-18 1999-12-07 New England Medical Center Hospitals, Inc. Biologically active fragments of IL-1β
US5122459A (en) * 1984-12-31 1992-06-16 Immunex Corporation Gene encoding biologically active human interleukin 1
EP0218700A4 (en) * 1985-04-23 1988-09-19 Medical Biology Inst IDENTIFICATION OF AN IgE BINDING PROTEIN BY MOLECULAR CLONING.
DE3683186D1 (de) 1985-04-25 1992-02-13 Hoffmann La Roche Rekombinantes humaninterleukin-1.
DE3650715T2 (de) * 1985-10-14 1999-06-24 Yeda Research And Development Co., Ltd., Rehovot Verwendung von menschlichem Interferon-Beta 2A für die Herstellung von Medikamenten
US5425940A (en) * 1986-04-09 1995-06-20 Cetus Oncology Corporation Combination therapy using interleukin-2 and tumor necrosis factor
US6284237B1 (en) 1986-07-08 2001-09-04 Steven C. Clark Methods of treatment using IL-6
IE67035B1 (en) * 1986-07-08 1996-02-21 Genetics Inst Production and use of non-glycosylated IL-6
EP0585957A1 (en) * 1986-08-06 1994-03-09 Ajinomoto Co., Inc. Recombinant B-cell differentiation factor
US4939093A (en) * 1987-02-02 1990-07-03 Cetus Corporation Human IL-2 like polypeptides, DNA sequences and recombinant DNA molecules therefore and methods for the production and use thereof
US4961969A (en) * 1987-05-11 1990-10-09 Cetus Corporation Process for recovering microbially produced interferon-β
IL88375A (en) * 1988-11-14 1995-07-31 Yeda Res & Dev Monoclonal antibodies that specifically bind interferon-bia 2 natural and recombinant and a natural and recombinant interferon-beta 2 purification method and method
US5338834A (en) * 1993-01-26 1994-08-16 Allelix Biopharmaceuticals Inc. Ultrapure human interleukin-6
US5723125A (en) * 1995-12-28 1998-03-03 Tanox Biosystems, Inc. Hybrid with interferon-alpha and an immunoglobulin Fc linked through a non-immunogenic peptide
US20050002902A1 (en) * 1995-12-28 2005-01-06 Liming Yu Hybrid with interferon-alpha and an immunoglobulin Fc for treatment of tumors and viral infections
US20030026779A1 (en) * 1999-10-15 2003-02-06 Liming Yu Treatment of tumors and viral infections with a hybrid conjugate of interferon and an immunoglobulin Fc
RU2318829C2 (ru) * 2001-11-14 2008-03-10 Сентокор, Инк. Антитела против il-6, композиции, способы и применение
US20050100550A1 (en) * 2003-11-10 2005-05-12 Mohit Trikha Anti-angiogenic uses of IL-6 antagonists
BRPI0507169A (pt) 2004-02-02 2007-06-26 Ambrx Inc polipeptìdeos do hormÈnio de crescimento humano modificados e seu usos
AU2009212311B8 (en) 2004-07-21 2013-05-30 Ambrx, Inc. Modified leptin polypeptides and their uses
PA8672101A1 (es) 2005-04-29 2006-12-07 Centocor Inc Anticuerpos anti-il-6, composiciones, métodos y usos
TWI501976B (zh) * 2007-05-21 2015-10-01 Alder Biopharmaceuticals Inc 抗ＴＮＦ－α之抗體及其用途
US20090238825A1 (en) * 2007-05-21 2009-09-24 Kovacevich Brian R Novel rabbit antibody humanization methods and humanized rabbit antibodies
US9701747B2 (en) 2007-05-21 2017-07-11 Alderbio Holdings Llc Method of improving patient survivability and quality of life by anti-IL-6 antibody administration
US8404235B2 (en) 2007-05-21 2013-03-26 Alderbio Holdings Llc Antagonists of IL-6 to raise albumin and/or lower CRP
US8178101B2 (en) 2007-05-21 2012-05-15 Alderbio Holdings Inc. Use of anti-IL-6 antibodies having specific binding properties to treat cachexia
KR101829776B1 (ko) 2007-05-21 2018-02-19 앨더바이오 홀딩스 엘엘씨 Ｉｌ-６에 대한 항체 및 이의 용도
US8062864B2 (en) * 2007-05-21 2011-11-22 Alderbio Holdings Llc Nucleic acids encoding antibodies to IL-6, and recombinant production of anti-IL-6 antibodies
US7906117B2 (en) 2007-05-21 2011-03-15 Alderbio Holdings Llc Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue, and/or fever
US8252286B2 (en) * 2007-05-21 2012-08-28 Alderbio Holdings Llc Antagonists of IL-6 to prevent or treat thrombosis
US8777182B2 (en) 2008-05-20 2014-07-15 Grinon Industries Fluid transfer assembly and methods of fluid transfer
US8188235B2 (en) 2008-06-18 2012-05-29 Pfizer Inc. Antibodies to IL-6 and their uses
US8337847B2 (en) 2008-11-25 2012-12-25 Alderbio Holdings Llc Methods of treating anemia using anti-IL-6 antibodies
US8323649B2 (en) 2008-11-25 2012-12-04 Alderbio Holdings Llc Antibodies to IL-6 and use thereof
US8420089B2 (en) 2008-11-25 2013-04-16 Alderbio Holdings Llc Antagonists of IL-6 to raise albumin and/or lower CRP
US9212223B2 (en) 2008-11-25 2015-12-15 Alderbio Holdings Llc Antagonists of IL-6 to prevent or treat thrombosis
US8992920B2 (en) 2008-11-25 2015-03-31 Alderbio Holdings Llc Anti-IL-6 antibodies for the treatment of arthritis
US9452227B2 (en) * 2008-11-25 2016-09-27 Alderbio Holdings Llc Methods of treating or diagnosing conditions associated with elevated IL-6 using anti-IL-6 antibodies or fragments
US9775921B2 (en) 2009-11-24 2017-10-03 Alderbio Holdings Llc Subcutaneously administrable composition containing anti-IL-6 antibody
EP2504030A4 (en) 2009-11-24 2013-06-26 Alderbio Holdings Llc IL-6 ANTAGONISTS FOR INCREASING ALBUMIN AND / OR REDUCING CRP
AU2011332817A1 (en) 2010-11-23 2013-06-13 Alder Biopharmaceuticals, Inc. Anti-IL-6 antibodies for the treatment of anemia

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4237224A (en) * 1974-11-04 1980-12-02 Board Of Trustees Of The Leland Stanford Jr. University Process for producing biologically functional molecular chimeras
FR2321298A1 (fr) * 1975-08-01 1977-03-18 Anvar Procede de preparation de produits a activite interferon
NZ187300A (en) * 1977-05-27 1982-08-17 Univ California Dna transfer vector and micro-organism modified to contain a nucleotide sequence equivalent to the gene of a higher organism
JPS5663996A (en) * 1979-10-30 1981-05-30 Japan Found Cancer Novel recombinant having gene complementary to human interferon messenger rna
US5326859A (en) * 1979-10-30 1994-07-05 Juridical Foundation, Japanese Foundation For Cancer Research DNA and recombinant plasmid
FI77877C (fi) * 1979-04-20 1989-05-10 Technobiotic Ltd Foerfarande foer framstaellning och rening av human le-formig interferonprotein.
US4262090A (en) * 1979-06-04 1981-04-14 Cetus Corporation Interferon production
US4289689A (en) * 1980-03-14 1981-09-15 Hoffmann-La Roche Inc. Preparation of homogeneous human fibroblast interferon
JPS5655731A (en) * 1979-10-11 1981-05-16 Ogura Clutch Co Ltd Clutch/brake device
NL7907791A (nl) * 1979-10-23 1981-04-27 Stichting Rega V Z W Werkwijze voor het zuiveren van interferon.
HU193507B (en) * 1980-04-03 1987-10-28 Biogen Nv Process for producing interferen-like pelypeptides
DE3177298T2 (de) * 1980-06-06 1993-07-01 Biogen Inc Verbesserte vektoren, verfahren zur herstellung solcher vektoren und zur expression von klonierten genen.

Also Published As

Publication number Publication date
FR2475901B1 (cg-RX-API-DMAC7.html) 1985-02-15
IT1194820B (it) 1988-09-28
CH684892A5 (de) 1995-01-31
US5468609A (en) 1995-11-21
DE3043981A1 (de) 1981-10-01
IL58765A0 (en) 1980-02-29
SE8007998L (sv) 1981-05-22
SE461223B (sv) 1990-01-22
JPS63164896A (ja) 1988-07-08
DE3051086C2 (cg-RX-API-DMAC7.html) 1992-11-05
IL58765A (en) 1986-09-30
US5541312A (en) 1996-07-30
JP2548201B2 (ja) 1996-10-30
SE8603145L (sv) 1986-07-17
JPH02211879A (ja) 1990-08-23
IT8026172A0 (it) 1980-11-21
US5468608A (en) 1995-11-21
JPS5685296A (en) 1981-07-11
DE3043981C2 (cg-RX-API-DMAC7.html) 1989-11-30
GB2063882A (en) 1981-06-10
JP2555279B2 (ja) 1996-11-20
CH664967A5 (de) 1988-04-15
FR2475901A1 (fr) 1981-08-21
GB2063882B (en) 1984-05-31
SE8603145D0 (sv) 1986-07-17
SE469660B (sv) 1993-08-16
US5468607A (en) 1995-11-21

Similar Documents

Publication Publication Date Title
SE461223C (sv) mRNA och cDNA för humant fibroblastinterferon, förfarande för deras framställning samt användning därav
Nagata et al. Synthesis in E. coli of a polypeptide with human leukocyte interferon activity
Chebath et al. Interferon-induced 56,000 Mr protein and its mRNA in human cells: molecular cloning and partial sequence of the cDNA
KR860001558B1 (ko) 인터페론의 제조방법
RU2092561C1 (ru) Способ получения полипептида со свойствами гамма-интерферона человека
KR940010865B1 (ko) 종양 괴사 인자의 생산 방법 및 종양 괴사 인자의 수율을 증가시키는 방법
EP0041313B1 (en) Dna sequences, recombinant dna molecules and processes for producing human fibroblast interferon
JP2558422B2 (ja) インターフェロンをコードする遺伝子
EP0083777B1 (en) Physiologically active peptide with between 147 and 162 amino acid residues
SE465223B (sv) Moget rekombinant-humanleukocytinterferon och foerfarande foer dess framstaellning
HU193512B (en) Process for preparing hybride interferones from human erythrocytes
JP2721139B2 (ja) 動物のインターフェロン
DK173054B1 (da) Fremgangsmåde til fremstilling af nyttige polypeptider ved genteknik, rekombinant BmNPV-DNA og vektor, der er anvendelig ve
Dixon et al. Organization and evolution of the protamine genes of salmonid fishes
JPS6361920B2 (cg-RX-API-DMAC7.html)
Langer et al. Purification, bacterial expression, and biological activities of the human interferons
JPH0745515B2 (ja) 新規インターフェロンγとその製造方法
EP0163603B1 (en) A human t-cell growth factor
Gren et al. Novel human leukocyte interferon subtype and structural comparison of alpha interferon genes
Wang et al. Comparative analysis of cellular and viral sequences related to sarcomagenic cell transformation
CN111233998B (zh) 一种犬干扰素CaIFN-λ突变体及其应用
WO1986006744A1 (en) A cDNA MOLECULE CODING FOR THE EXPRESSION OF AN INTERFERON alpha TYPE POLYPEPTIDE, A BACTERIAL OR CELLULAR HOST TRANSFORMED WITH SUCH MOLECULE AND A POLYPEPTIDE SHOWING INTERFERON ACTIVITY PREPARED BY SUCH HOST
Shiroki et al. Activation of the human beta interferon gene by the adenovirus type 12 E1B gene
NO894598L (no) Bovinmetallotionein regulatorisk omraade.
KR890001828B1 (ko) 인터페론-α형의 폴리펩티드의 제조방법

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8007998-1

Format of ref document f/p: F